🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseQuit drinking AND started sema - liver is thanking me — looking for input Page 6

Quit drinking AND started sema - liver is thanking me — looking for input

Dr.LipidDallas Fri, Mar 22, 2024 at 4:23 AM 48 replies 2,428 viewsPage 6 of 10
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Apr 23, 2024 at 12:18 PM#26

Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

45 18MikeFit_NJ, InsuranceTom, WendyG_ATL and 42 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Apr 27, 2024 at 12:58 PM#27
Dr.PathRoch said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Same pattern here, and in the same order. The detail I would add is minor and it is already implied above.

Last edited: Apr 27, 2024 at 4:58 PM
46 19sarah_TO, wendy_avl, jason_paloalto and 43 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
May 1, 2024 at 1:36 PM#28
Dr.PathRoch said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Adding the part of the answer the thread has not reached. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

47 20FitDadDave, RunnerRach, TrialNerd_Beth and 44 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
May 5, 2024 at 2:11 PM#29

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

I would rather be corrected than agreed with, if it comes to it.

48 21Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 45 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
May 9, 2024 at 2:44 PM#30

Closing the loop on my own question.

Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Last edited: May 9, 2024 at 4:44 PM
20 18Dr.PulmRoch, maya_sedona, stefan_berlin and 17 others
Reply Quote Save Share Report
14567810

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register